Morgan Stanley
ONEM

Morgan Stanley’s 1Life Healthcare ONEM Stock Holding History

Morgan Stanley’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,105,890
Closed -$18.5M – 7946
2022
Q4 		$18.5M Sell
1,105,890
-109,330
-9% -$1.85M ﹤0.01% 2419
2022
Q3 		$20.8M Buy
1,215,220
+630,732
+108% +$9.9M ﹤0.01% 2144
2022
Q2 		$4.58M Buy
584,488
+84,672
+17% +$727K ﹤0.01% 3844
2022
Q1 		$5.54M Sell
499,816
-180,203
-26% -$2.02M ﹤0.01% 3572
2021
Q4 		$11.9M Sell
680,019
-289,183
-30% -$5.61M ﹤0.01% 2748
2021
Q3 		$19.6M Sell
969,202
-188,913
-16% -$4.86M ﹤0.01% 2106
2021
Q2 		$38.3M Buy
1,158,115
+250,082
+28% +$9.44M 0.01% 1530
2021
Q1 		$35.5M Sell
908,033
-67,434
-7% -$3.17M 0.01% 1435
2020
Q4 		$42.6M Buy
975,467
+302,504
+45% +$10.3M 0.01% 1204
2020
Q3 		$19.1M Buy
672,963
+401,793
+148% +$12.7M ﹤0.01% 1526
2020
Q2 		$9.85M Buy
271,170
+226,936
+513% +$6.39M ﹤0.01% 1980
2020
Q1 		$803K Buy
+44,234
New +$970K ﹤0.01% 4102

Morgan Stanley's ONEM Position: Q1 2023 in Review

Morgan Stanley sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,105,890 shares — an estimated $18.5M sold.

Morgan Stanley first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $42.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Morgan Stanley reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 1,105,890 1Life Healthcare shares in Q1 2023, an estimated $18.5M.
  • Morgan Stanley first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Morgan Stanley's 1Life Healthcare position peaked at $42.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.